CareMax, Inc.

Equities

CMAX

US14171W2026

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
2.865 USD -12.12% Intraday chart for CareMax, Inc. +19.38% -80.83%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Trims CareMax Price Target to $6.40 From $7, Maintains Neutral Rating MT
Transcript : CareMax, Inc., Q4 2023 Earnings Call, Mar 18, 2024
Earnings Flash (CMAX) CAREMAX Reports Q4 Revenue $151.8M MT
CareMax, Inc. Reports Unaudited Consolidated Goodwill Impairment for the Fourth Quarter Ended December 31, 2023 CI
CareMax, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
CareMax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CareMax, Inc.(NasdaqGS:CMAX) dropped from S&P Global BMI Index CI
North American Morning Briefing : Powell Still in -2- DJ
UBS Adjusts CareMax Price Target to $7 From $30, Maintains Neutral Rating MT
CareMax to Implement 1-for-30 Reverse Stock Split MT
North American Morning Briefing : Stocks Futures -2- DJ
UBS Downgrades CareMax to Neutral From Buy, Adjusts Price Target to $1 From $5 MT
North American Morning Briefing : Stock Futures -2- DJ
Piper Sandler Downgrades CareMax to Neutral From Overweight With $2 Price Target MT
Transcript : CareMax, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (CMAX) CAREMAX Reports Q3 Revenue $201.8M MT
Caremax, Inc. Reports Unaudited Goodwill Impairment for the Three Months Ended September 30, 2023 CI
CareMax, Inc. Reaffirms Earnings Guidance for the Year 2023 CI
CareMax, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
CareMax, Inc. Announces Resignation of David J. Shulkin as A Member of the Board of Director CI
CareMax, Inc. Announces Resignation of Ms. Beatriz Assapimonwait as Member of the Board of Directors of the Company, Effective October 5, 2023 CI
Transcript : CareMax, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 07:30 AM
Transcript : CareMax, Inc., Q2 2023 Earnings Call, Aug 09, 2023
Earnings Flash (CMAX) CAREMAX Posts Q2 Revenue $224.4M, vs. Street Est of $184.3M MT
Caremax, Inc. Raises Revenue Guidance for the Full Year of 2023 CI
Chart CareMax, Inc.
More charts
CareMax, Inc. is a technology-enabled care platform providing value-based care and chronic disease management through physicians and health care professionals committed to the overall health and wellness continuum of care for its patients. It operates over 56 centers and managed affiliated providers across 10 states that offer a suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Its CareOptimize is an end-to-end technology platform that aggregates and analyzes data using proprietary algorithms and machine learning to support more informed care delivery decisions and to focus care decisions on preventative chronic disease management and the social determinants of health. The Company offers 24/7 access to care through employed providers and provides a comprehensive suite of high-touch health care and social services for its patients.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.26 USD
Average target price
4.7 USD
Spread / Average Target
+44.17%
Consensus
  1. Stock Market
  2. Equities
  3. CMAX Stock
  4. News CareMax, Inc.
  5. CareMax Swings to Loss in Q2, Revenue Rises; Increases 2022 Guidance